Stockscreener 앱 받기
57.20
4.27%
2.34
시장 영업 전:
57.18
-0.02
-0.03%
Lantheus Holdings Inc 주식(LNTH)의 최신 뉴스
Lantheus Holdings (LNTH) Dives 28.6% on Tempered Growth Outlook - MSN
Lantheus lowers 2025 revenue and EPS outlook, targets $1.475B–$1.51B revenue as pricing pressures persist - MSN
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q2 2025 Earnings Call Transcript - Insider Monkey
Lantheus Holdings, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - uk.finance.yahoo.com
Lantheus Holdings Inc’s Mixed Earnings Call: Challenges and Strategic Advances - TipRanks
Best Mid Cap Stocks To ResearchAugust 6th - MarketBeat
LNTH: Competition Escalates in PSMA Imaging - Zacks Small Cap Research
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns - Investing.com Australia
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns By Investing.com - Investing.com South Africa
Did Lantheus Holdings, Inc. (LNTH) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire
Lantheus Holdings: Mizuho Downgrades to Outperform, PT to $70 from $120. - AInvest
Lantheus (LNTH) shares plummet 33.1% to $48.62. - AInvest
Lantheus Holdings 2025 Q2 Earnings Earnings Surge 26.9% Despite Revenue Dip - AInvest
Lantheus Holdings shares rise 1.79% premarket after announcing a $400 million share repurchase program. - AInvest
Lantheus stock price target lowered to $73 at JMP on pricing pressure - Investing.com Australia
Lantheus Holdings (LNTH) Announces US$400 Million Buyback Amid FDA and Earnings Updates - simplywall.st
Lantheus Holdings Reports Q2 2025 Results and Strategic Moves - TipRanks
Lantheus Shares Tumble 28.58% on $700M Trading Surge to 143rd Rank as FDA Progress and Strategic Moves Unfold - AInvest
Lantheus Holdings shares rise 1.18% after-hours after announcing a $400 million share repurchase program. - AInvest
FDA accepts Lantheus’ NDA for new Pylarify formulation - AuntMinnie
Lantheus Holdings: Q2 Earnings Snapshot - Chron
Why Lantheus (LNTH) Stock Is Falling Today - Yahoo Finance
Lantheus Shares Slide As Earnings And Outlook Fall Short - Finimize
Tranche Update on Lantheus Holdings, Inc.'s Equity Buyback Plan announced on November 20, 2024. - MarketScreener
Lantheus Holdings, Inc. announces an Equity Buyback for $400 million worth of its shares. - MarketScreener
Lantheus Q2 2025 slides: revenue falls 4.1%, company slashes full-year guidance - Investing.com Canada
Lantheus Holdings: Reassessing The Buy Thesis (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings stock hits 52-week low at $51.75 By Investing.com - Investing.com Australia
Lantheus Holdings stock hits 52-week low at $51.75 - Investing.com
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge - Investing.com India
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge By Investing.com - Investing.com Nigeria
Lantheus Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lantheus announces FDA review for new radioactive imaging agent - MSN
Lantheus Holdings Inc Q2 2025 Earnings: EPS Surges to $1.12, Bea - GuruFocus
Lantheus Holdings Inc earnings missed by $0.10, revenue fell short of estimates - Investing.com
Lantheus Q2 Adjusted Earnings, Revenue Fall; Lowers 2025 Guidance; Shares Drop Pre-Bell - MarketScreener
Lantheus Holdings Plunges 22.21% on Missed Q2 Earnings - AInvest
Lantheus Announces FDA Acceptance of New Drug Application - TipRanks
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8% - Yahoo Finance
Lantheus Holdings, Inc. SEC 10-Q Report - TradingView
Why Lantheus Shares Are Taking a Hit - TipRanks
Lantheus stock slips on Q2 miss amid regulatory win (LNTH) - Seeking Alpha
FDA accepts Lantheus’ NDA for new PSMA PET imaging formulation By Investing.com - Investing.com Nigeria
FDA accepts Lantheus’ NDA for new PSMA PET imaging formulation - Investing.com India
Riley Reduces Lantheus Holdings (LNTH) PT to $109, Maintains Buy Rating - MSN
Earnings Flash (LNTH) Lantheus Holdings, Inc. Posts Q2 Adjusted EPS $1.57 per Share, vs. FactSet Est of $1.68 - MarketScreener
Lantheus Q2 rev. $378mln, adj. EPS $1.57, FDA okays new imaging agent, buys Life Molecular Imaging. - AInvest
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update - Stock Titan
Breakthrough: FDA Reviews New PSMA Imaging Formula That Could Help Thousands More Prostate Cancer Patients - Stock Titan
Lantheus Q2 Earnings Preview: Analyst Expectations and Potential Upside - AInvest
Lantheus (LNTH) Reports Q2: Everything You Need To Know Ahead Of Earnings - MSN
Lantheus Holdings Inc (LNTH) Q2 2025: Everything You Need To Kno - GuruFocus
Lantheus Holdings Inc (LNTH) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Lantheus Holdings (NASDAQ:LNTH) shareholders have earned a 39% CAGR over the last five years - uk.finance.yahoo.com
0.43%
0.47%
자본화:
|
볼륨(24시간):